Top

Diabetology & Metabolic Syndrome

Published in:

Open Access 01-12-2010 | Research

Anxiety and depression among outpatients with type 2 diabetes: A multi-centre study of prevalence and associated factors

Authors: Ali Khan Khuwaja, Saima Lalani, Raheem Dhanani, Iqbal Syed Azam, Ghazala Rafique, Franklin White

Published in: Diabetology & Metabolic Syndrome | Issue 1/2010

Abstract

Background

Anxiety and depression contribute to poor disease outcomes among individuals with diabetes. This study aimed to assess the prevalence of anxiety and depression and to identify their associated factors including metabolic components among people with type 2 diabetes.

Methods

We conducted a cross-sectional, multi-center study in four out-patient clinics in Karachi, Pakistan. In all, 889 adults with type-2 diabetes were included in this study. Anxiety and depression were measured by using the Hospital Anxiety and Depression Scale (HADS). Multivariable analysis using multiple logistic regression was carried out to evaluate the combined effect of various factors associated with anxiety and depression, while adjusting for confounding variables.

Results

Overall, 57.9% (95% CI = 54.7%, 61.2%) and 43.5% (95% CI = 40.3%, 46.8%) study participants had anxiety and depression respectively. Factors found to be independently associated with anxiety were physical inactivity, having hypertension and ischemic heart disease. For depression, being female, of older age, having hypertension and ischemic heart disease were significantly associated. Metabolic components found to be independently associated with both anxiety and depression were systolic blood pressure, fasting blood glucose and fasting blood triglycerides. Body mass index was independently associated with depression but not with anxiety.

Conclusion

This study identified that a large proportion of adults with diabetes had anxiety and/or depression, and identified factors associated with these entities. These results alert clinicians to identify and treat anxiety and depression as common components of diabetes care. Additional studies are needed to establish the directional nature of this relationship and to test interventions.

International Diabetes Federation. Diabetes Atlas. Accessed May 3nd, 2010, [http://www.worlddiabetesfoundation.org/composite-35.htm]4

Khuwaja AK, Qureshi R, Azam SI: Prevalence and factors associated with anxiety and depression among family practitioners in Karachi, Pakistan. J Pak Med Assoc. 2004, 54: 45-49.PubMed

Khowaja LA, Khuwaja AK, Cosgrove P: Cost of diabetes care in out-patient clinics of Karachi, Pakistan. BMC Health Serv Res. 2007, 21: 189-10.1186/1472-6963-7-189.CrossRef

Lin EH, Rutter CM, Katon W, Heckbert SR, Ciechanowski P, Oliver MM, et al: Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care. 2010, 33: 264-269. 10.2337/dc09-1068.PubMedCentralCrossRefPubMed

Ali S, Stone M, Skinner TC, Robertson N, Davies M, Khunti K: The association between depression and health-related quality of life in people with type 2 diabetes: a systematic literature review. Diabetes Metab Res Rev. 2010, 26: 75-89. 10.1002/dmrr.1065.CrossRefPubMed

Nichols l, Barton PL, Glazner J, McCollum M: Diabetes, minor depression and health care utilization and expenditures: a retrospective database study. Cost Eff Resour Alloc. 2007, 5: 4-10.1186/1478-7547-5-4.PubMedCentralCrossRefPubMed

Bouwman V, Adriaanse MC, van 't Riet E, Snoek FJ, Dekker JM, Nijpels G: Depression, anxiety and glucose metabolism in the general Dutch population: the new Hoorn study. PloS One. 2010, 5: e9971-10.1371/journal.pone.0009971.PubMedCentralCrossRefPubMed

Pouwer F: Should we screen for emotional distress in type 2 diabetes mellitus?. Nat Rev Endocrinol. 2009, 5: 665-71. 10.1038/nrendo.2009.214.CrossRefPubMed

Vogelzangs N, Suthers K, Ferrucci L, Simonsick EM, Ble A, Schrager M, et al: Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology. 2007, 32: 151-159. 10.1016/j.psyneuen.2006.11.009.PubMedCentralCrossRefPubMed

10.

Danese A, Moffitt TE, Harrington H, Milne BJ, Polanczyk G, Pariante CM, et al: Adverse childhood experiences and adult risk factors for age-related disease, et al: depression, inflammation, and clustering of metabolic risk markers. Arch Pediatr Adolesc Med. 2009, 163: 1135-1143. 10.1001/archpediatrics.2009.214.PubMedCentralCrossRefPubMed

11.

Ciechanowski PS, Katon WJ, Russo JE: Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000, 160: 3278-3285. 10.1001/archinte.160.21.3278.CrossRefPubMed

12.

Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L, Wittenberg E, et al: Depression, self-care, and medication adherence in type 2 diabetes: relationship across the full range of symptom severity. Diabetes Care. 2007, 30: 2222-2227. 10.2337/dc07-0158.PubMedCentralCrossRefPubMed

13.

Katon W: Depression and diabetes: unhealthy bedfellows. Depression Anxiety. 2010, 27: 323-326. 10.1002/da.20683.PubMedCentralCrossRefPubMed

14.

Simon GE, Katon WJ, Lin EH, Rutter C, Manning WG, Von Korff M, et al: Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. Arch Gen Psychiatry. 2007, 64: 65-72. 10.1001/archpsyc.64.1.65.CrossRefPubMed

15.

Collins MM, Corcorant P, Perry IJ: Anxiety and depression symptoms in patients with diabetes. Diabet Med. 2009, 26: 153-161. 10.1111/j.1464-5491.2008.02648.x.CrossRefPubMed

16.

Egede LE, Zheng D, Simpson K: Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002, 25: 464-470. 10.2337/diacare.25.3.464.CrossRefPubMed

17.

Katon W, Russo J, Lin EH, Heckbert SR, Ciechanowski P, Ludman EJ, et al: Depression and diabetes: factors associated major depression at five-year follow up. Psychosomatics. 2009, 50: 570-579. 10.1176/appi.psy.50.6.570.PubMedCentralCrossRefPubMed

18.

Takeuchi T, Nakao M, Nomura K, Inoue M, Tsurugano S, Shinozaki Y, et al: Association of the metabolic syndrome with depression and anxiety in Japanese men, et al: a 1-year cohort study. Diabetes Metab Res Rev. 2009, 25: 762-767. 10.1002/dmrr.1041.CrossRefPubMed

19.

Dunbar JA, Reddy P, Davis-Lameloise N, Philpot B, Laatikainen T, Kikkinen A, et al: Depression: an important comorbidity with metabolic syndrome in a general population. Diabetes Care. 2008, 31: 2368-2373. 10.2337/dc08-0175.PubMedCentralCrossRefPubMed

20.

Hildrum B, Mykletun A, Midthjell K, Ismail K, Dahl AA: No association of depression and anxiety with the metabolic syndrome: the Norwegian HUNT study. Acta Psychiatr Scand. 2009, 120: 14-22. 10.1111/j.1600-0447.2008.01315.x.CrossRefPubMed

21.

Dogar IA, Khawaja IS, Azeem MW, Awan H, Ayub a, Iqbal J, et al: Prevalence and risk factors for depression and anxiety in hospitalized cardiac patients in Pakistan. Psychiatry (Edgmont). 2008, 5: 38-41.

22.

Labad J, Price JF, Strachan MWJ, Fowkes FGR, Ding J, Deary IJ, et al: Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetologia. 2010, 53: 467-471. 10.1007/s00125-009-1628-9.PubMedCentralCrossRefPubMed

23.

Paddison CA, Eborall HC, French DP, Kinmonth AL, Griffin SJ, Sutton S: Predictors of anxiety and depression among people attending diabetes screening: A prospective cohort study embedded in the ADDITION (Cambridge) randomized control trial. Br J Health Psychol. 2010,

24.

Mosaku K, Kolawole B, Mume C, Ikem R: Depression, anxiety and quality of life among diabetic patients: a comparative study. J Natl Med Assoc. 2008, 100: 73-8.PubMed

25.

Lin EH, Heckbert SR, Rutter CM, Katon WJ, Ciechanowski P, Ludman EJ, et al: Depression and increased mortality in diabetes: unexpected causes of death. Ann Fam Med. 2009, 7: 414-421. 10.1370/afm.998.PubMedCentralCrossRefPubMed

26.

Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B: Depression, chronic diaease, and decrements in health: results from the World Health Surveys. Lancet. 2007, 370: 851-858. 10.1016/S0140-6736(07)61415-9.CrossRefPubMed

27.

Maharaj RG, Reid SD, Misir A, Simeon DT: Depression and its associated factors among patients attending chronic disease clinics in southwest Trinidad. West Indian Med J. 2005, 54: 369-374.PubMed

28.

Stein DJ, Gureje O: Depression and anxiety in the developing world: is it time to medicalize their suffering. Lancet. 2004, 364: 233-234. 10.1016/S0140-6736(04)16693-2.CrossRefPubMed

29.

Mirza I, Jenkins R: Risk factors, prevalence, and treatment of anxiety and depressive disorders in Pakistan: systemic review. BMJ. 2004, 328: 794-10.1136/bmj.328.7443.794.PubMedCentralCrossRefPubMed

30.

Khuwaja AK, Kadir MM: Gender differences and clustering patterns of behavioral risk factors for chronic non-communicable diseases: community-based study from a developing country. Chronic Illn. 2010, 6 (3): 163-170. 10.1177/1742395309352255.CrossRefPubMed

31.

Almawi W, Tamim H, Al-Sayed N, Arekat MR, Al-Khateeb GM, Baqer A, et al: Association of comorbid depression, anxiety and stress disorders with type 2 diabetes in Bahrain, a country with a very high prevalence of type 2 diabetes. J Endocrinol Invest. 2008, 31: 1020-1024.CrossRefPubMed

32.

Ganatra HA, Zafar SN, Qidwai W, Rozi S: Prevalence and predictors of depression among an elderly population of Pakistan. Aging Ment Health. 2008, 12: 349-356. 10.1080/13607860802121068.CrossRefPubMed

33.

Iype T, Shaji SK, Balakrishnan A, Charles D, Varghese A, Antony TP: Cognition in type 2 diabetes: association with vascular risk factors, complications of diabetes and depression. Ann Indian Acad Neurol. 2009, 12: 25-27.PubMedCentralPubMed

34.

Craft LL, Freund KM, Culpepper L, Perna FM: Intervention study of exercise for depressive symptoms in women. J Women Health (Larchmt). 2007, 16: 1499-1509. 10.1089/jwh.2007.0483.CrossRef

35.

Craft LL, Perna FM: The benefits of exercise for the clinically depressed. Prim Care Companion J Clin Psychiatry. 2004, 6: 104-111. 10.4088/PCC.v06n0301.PubMedCentralCrossRefPubMed

36.

Hong X, Li J, Xu F, Tse LA, Liang Y, Wang Z, et al: Physical activity inversely associated with the presence of depression among urban adolescents in regional China. BMC Public Health. 2009, 9: 148-10.1186/1471-2458-9-148.PubMedCentralCrossRefPubMed

37.

Thomas J, Jones G, Scarinci I, Brantley P: A descriptive and comparative study of the prevalence of depressive and anxiety disorders in low-income adults with type 2 diabetes and other chronic illnesses. Diabetes Care. 2003, 26: 2311-7. 10.2337/diacare.26.8.2311.CrossRefPubMed

38.

Herva A, Räsänen P, Miettunen J, Timonen M, Läksy K, Veijola J, et al: Co-occurrence of metabolic syndrome with depression and anxiety in young adults: The Northern Finland 1966 Birth Cohort Study. Psychosom Med. 2006, 68: 213-216. 10.1097/01.psy.0000203172.02305.ea.CrossRefPubMed

39.

Perveen S, Otho MS, Siddiqi MN, Hatcher J, Rafique G: Association of depression with newly diagnosed type 2 diabetes among adults aged between 25 to 60 years in Karachi, Pakistan. Diabetol Metab Syndr. 2010, 2: 17-10.1186/1758-5996-2-17.PubMedCentralCrossRefPubMed

Title: Anxiety and depression among outpatients with type 2 diabetes: A multi-centre study of prevalence and associated factors
Authors: Ali Khan Khuwaja
Saima Lalani
Raheem Dhanani
Iqbal Syed Azam
Ghazala Rafique
Franklin White
Publication date: 01-12-2010
Publisher: BioMed Central
Published in: Diabetology & Metabolic Syndrome / Issue 1/2010
Electronic ISSN: 1758-5996
DOI: https://doi.org/10.1186/1758-5996-2-72

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Anxiety and depression among outpatients with type 2 diabetes: A multi-centre study of prevalence and associated factors

Abstract

Background

Methods

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2010

Oral Insulin

Association of depression with newly diagnosed type 2 diabetes among adults aged between 25 to 60 years in Karachi, Pakistan

Association between insulin resistance and c-reactive protein among Peruvian adults

Assessment of cognitive status in patients with type 2 diabetes through the mini-mental status examination: a cross-sectional study

Repercussions of mild diabetes on pregnancy in Wistar rats and on the fetal development

Sedentary subjects have higher PAI-1 and lipoproteins levels than highly trained athletes

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page